Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
Condition: Prostate Cancer Interventions: Drug: DFMO; Drug: testosterone cypionate; Drug: Luteinizing hormone-releasing hormone (LHRH) analogue; Drug: Enzalutamide Sponsors: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Panbela Therapeutics; Prostate Cancer Foundation; United States Department of Defense Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials